Chemical Synthesis of Astatine Labelled ASCT2 Inhibitor Analogue (HA01) as a Radiotherapeutic Agent for Theranostics

Authors

Hawk Azordegan, The University of Texas MD Anderson Cancer Center
Cong-Dat Pham, The University of Texas MD Anderson Cancer Center
Henry Charles Manning, The University of Texas MD Anderson Cancer Center

Files

Program Affiliation

CPRIT-CURE Summer Undergraduate Program

Recommended Citation

Azordegan, Hawk; Pham, Cong-Dat; and Manning, Henry Charles, "Chemical Synthesis of Astatine Labelled ASCT2 Inhibitor Analogue (HA01) as a Radiotherapeutic Agent for Theranostics" (2022). Summer Experience 2022. 47.
https://openworks.mdanderson.org/sumexp22/47